TriOptic-P

This page contains information on TriOptic-P for veterinary use.
The information provided typically includes the following:
  • TriOptic-P Indications
  • Warnings and cautions for TriOptic-P
  • Direction and dosage information for TriOptic-P

TriOptic-P

This treatment applies to the following species:
Manufacturer: Zoetis

(bacitracin-neomycin-polymyxin)

Sterile Veterinary Ophthalmic Ointment

Antibacterial

TriOptic-P Caution

Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Description

Each gram contains bacitracin zinc 400 units, neomycin sulfate 5 mg (equivalent to 3.5 mg of neomycin base), polymyxin B sulfate 10,000 units, in a base of white petrolatum and mineral oil.

ACTIONS: The 3 antibiotics present in TriOptic-P Veterinary Ophthalmic Ointment provide a broad spectrum of activity against the gram-positive and gram-negative bacteria commonly involved in superficial infections of the eyelid and conjunctiva. Bacitracin is effective against gram-positive bacteria including hemolytic and non-hemolytic Streptococci and Staphylococci. Resistant strains rarely develop. Neomycin is effective against both gram-positive and gram-negative bacteria including Staphylococci, Escherichia coli, Haemophilus influenzae, and many strains of Proteus and Pseudomonas. Polymyxin B is bactericidal to gram-negative bacteria especially Pseudomonas. No resistant strains have been found to develop in vivo.

TriOptic-P Indications

In the treatment of superficial bacterial infections of the eyelid and conjunctiva in dogs and cats when due to organisms susceptible to the antibiotics contained in the ointment. Laboratory tests should be conducted including in vitro culturing and susceptibility tests on samples collected prior to treatment.

Precautions

Sensitivity to TriOptic-P Veterinary Ophthalmic Ointment is rare; however, if a reaction occurs, discontinue use of the preparation. As with any antibiotic preparation, prolonged use may result in the overgrowth of nonsusceptible organisms including fungi. Appropriate measures should be taken if this occurs. If infection does not respond to treatment in 2 or 3 days, the diagnosis and therapy should be reevaluated.

Care should be taken not to contaminate the applicator tip of the tube during application of the preparation. Do not allow the applicator tip to come in contact with any tissue.

Adverse Reactions

Itching, burning or inflammation may occur in animals sensitive to the product. Discontinue use in such cases.

Dosage and Administration

Apply a thin film over the cornea 3 or 4 times daily in dogs and cats. The area should be properly cleansed prior to use. Foreign bodies, crusted exudates, and debris should be carefully removed.

WARNINGS: Do not use this product as a presurgical ocular lubricant. Adverse reactions of ocular irritation and corneal ulcerations have been reported in association with such use.

How Supplied

3.5-gram (1/8-oz), sterile, tamper-proof tubes.

STORE AT ROOM TEMPERATURE

NADA #65-016, Approved by FDA

Manufactured by: Altana Inc. Melville, NY 11747, USA.

Distributed by: Pfizer Animal Health, Exton, PA 19341, USA. Div. of Pfizer Inc NY, NY 10017.

9812 75-8276-03

IF12838B PFIZER

#93

NAC No.: 36901451

ZOETIS INC.
333 PORTAGE STREET, KALAMAZOO, MI, 49007
Telephone:   269-833-4000
Customer Service:   888-963-8471
Website:   www.zoetis.com
Every effort has been made to ensure the accuracy of the TriOptic-P information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2014 North American Compendiums. Updated: 2014-04-11

(web4)